MSQ: SOUTH KOREA BIOPHARMA BRIEF
South Korea is an established biopharma centerpiece in both the global and APAC markets. Its biopharma market grows rapidly which has been attributed to the support from the government, venture capitals, talents pools and favorable geopolitical environment.
South Korea is an attractive market for foreign countries looking for collaborations. Most notably, South Korea is highlighted for their outstanding clinical trials, due to a dense hospital population, fast approval process, and increased trial efficiency and quality.
Overall, although certain challenges exist, South Korea will continue playing an important role in the global biopharma market.
This report provides a brief overview of the South Korea Biopharma Industry.